Variant · Snv
TP53 R280G
CI-VAR-00003806Explore in graph →CIViC 5559
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 40333905
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Unmapped disease1unmapped disease | ||||||||
| TP53 R280G | (functional) | Functional | E | Supports Loss Of Function | 2 | submitted | EID13197In computational analyses of TP53 variants identified in HNSCC datasets, R280G was predicted to destabilize TP53 by I-MUTANT (ΔΔG −2.53), MUpro (score −1.466), and CUPSAT (score −1.26), and altered pr… (full text at CIViC) PMID 40333905 · Mahmoud et al., 2025 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available